Sabine Leclercq

Sabine Leclercq currently serves as a senior leader at GSK Vaccines, bringing over 22 years of experience in the biopharmaceutical industry. Her expertise spans across CMC (Chemistry, Manufacturing, and Controls) for vaccines, small molecules, and large molecules. Sabine has successfully led large and global CMC organisations, managing teams of over 1000 people.

Her extensive experience includes technical development in drug substance, drug product, analytical methods, clinical manufacturing, and digital transformation. As an R&D Site Director, Sabine has been at the forefront of regulatory interactions, including FDA, EMEA, China, and Japan regulations.

Sabine's contributions to the field are recognised through her leadership and technical acumen, making her a valuable asset to GSK Vaccines and the broader biopharmaceutical community.